AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2690-1919/059
1 Azerbaijan State Advanced Training Institute for Doctors named by A. Aliyev, department of psychiatry and drug addiction, Baku, Azerbaijan.
2 Azerbaijan Medical University, department of psychiatry Baku, Azerbaijan.
*Corresponding Author: Nadir A. Aliyev, Department of psychiatry and addiction, Azerbaijan State Advanced Training Institute, Baku, Azerbaijan.
Citation: NA Aliyev and ZN Aliyev. The Combined Use of Carbamazepine and Lithium in the Treatment of Outpatients with Rapid Cycle Bipolar Disorder without Psychiatric Comorbidity: Randomized, Double-Blind Placebo-Controlled Study. J Clinical Research and Reports, 4(2); DOI:10.31579/2690-1919/059
Copyright: © 2020 Nadir A. Aliyev. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 27 February 2020 | Accepted: 09 April 2020 | Published: 05 May 2020
Keywords: rapid cycle bipolar disorder; carbamazepine; lithium; treatment
Objective. — Rapid cycle bipolar disorder may be more resistant to treatment than other bipolar types. However, the effect of the combined use of carbamazepine and lithium in the treatment of outpatients with rapid cycle bipolar disorder without psychiatric comorbidity has not been studied in a double-blind placebo-controlled design. The study periods: from January 1, 2016 to January 2019. Patients were observed at the Mental Health Center of the Ministry of Health of the Republic of Azerbaijan.
Materials and methods. —Eligible participants to meeting the DSM-5criteria for rapid cycle bipolar disorder was a double-blind, placebo-controlled trial, were required to be between 18 and 65 years. Response and side effects with carbamazepine and lithium and placebo were compared by using analysis of variance (ANOVA) and chi-square tests. The responder was conducted by X2 ademonstrated superior for carbamazepine and lithium than for placebo. Carbamazepine and lithium was generally well tolerated by the patients in the study, although more carbamazepine and lithium -treated patients (n = 2) discontinued the study early because of adverse events.
Results. — Twenty seven of the 36 combined use of carbamazepine and lithium -treated participants responded by 12 weeks, versus six of the 38 placebo-treated participant! (p < 0.001). The responder was conducted by X2 demonstrated superior for carbamazepine and lithium than for placebo. Common side effects leading to discontinuation in the carbamazepine and lithium group were allergic reaction and drowsiness. Sweating and headache frequent complaint during placebo treatment occurred in two of 38 men. There were not unexpected or serious adverse events.
Conclusions. — The combined use of carbamazepine and lithium in the treatment of outpatients with Rapid cycle bipolar disorder demonstrated superior for carbamazepine and lithium than for placebo.
According the epidemiological data the prevalence of bipolar disorder DSM-5 over the course of 12 months and throughout life was 1.5% and 2.1% and did not differ between men (1.6% and 2.2%) and women (1.5% and 2 , 0%) [4].
Total spending on bipolar disorder type I (BDI) in 2015 was estimated at $ 202.1 billion, which corresponds to an average of $ 81,559 per person, while excess spending on BDI was estimated at $ 119.8 billion, which corresponds to an average of 48 333 USD per person [10].
The total cost of mental illness is estimated at more than 4% of GDP - or more than 600 billion Euros in 28 EU countries. Severe mental illness, such as bipolar disorder, affects nearly 5 million people (1.0% of the population), while schizophrenic disorders affect another 1.5 million people (0.3%) [20].
Available literature indicates that the pharmacological treatment of fast cycling is still scarce, and therefore there is no consensus on its optimal pharmacological treatment. Clinical trials specifically studying rapid cycling are needed to unravel the proper management of bipolar disorder with rapid cycling [11]. Some authors conclude that rapid cycling is a common, albeit insufficiently recognized, condition for bipolar disorder, and it represents a worsening of the primary disorder. There is no convincing evidence that fast cycling is a separate subtype. Early recognition of this pattern can lead to an improvement in treatment strategy and an improvement in the long-term course. Conceptualizing fast cycling according to the results of these studies should be an important step forward [8].
Pharmacotherapy for rapid cycle bipolar disorder is an active area of research. A variety of drug groups have been shown to be effective in treating many of the rapid cycle bipolar disorder. From a therapeutic point of view, a previous study showed the effectiveness of several drugs. For example, lamotrigine is known to increase euthyma in patients with RCBD compared with placebo [13]. In addition, pramiprexol has been shown to facilitate resistant depression in patients with RBC [1]. In patients with concomitant pathological conditions, such as hypothyroidism, levothyroxine supplementation has been shown to eliminate the symptoms of RCBD in patients [9]. Finally, it has also been shown that ketamine is extremely useful in patients with RBC with active suicidal ideation [29]. Bipolar disorder is characterized by episodes of mood that almost always recur Patients who experience at least four episodes over a 12-month period are classified as “rapid cycles” . Patients who experience at least four episodes during a 12-month period are classified as “rapid cycling” [2]. The term was first used to describe bipolar patients who did not respond to lithium [20]. However, it is now clear that all drugs (including lithium) are less effective for patients with “rapid cycles” than patients with non-“rapid cycles” [29].
Rapid cycle bipolar disorder) may be more resistant to treatment than other bipolar types. In the open phase of the two-phase study, 133 depressed patients with rapid cycle bipolar disorder began to take lithium plus divalproex. Only 14% stabilized; 10% withdrew due to side effects; 17% were not committed. In the double-blind phase, 49 respondents were not randomized to placebo or lamotrigine. The two groups showed no differences in response rates. [20].
Studies show that the rapid cycle is different from other forms of bipolar disorder. People with such mood changes may respond differently to standard and experimental treatments than other people with bipolar disorder. With his sudden and unpredictable mood changes, rapid cycles can be more difficult than other types of bipolar disorder.
For rapid cycling (can be used for bipolar disorder I or bipolar disorder II): at least four episodes of mood during the previous 12 months that meet the criteria for a manic, hypomanic or major depressive episode. Episodes are limited to partial or complete remission for at least 2 months or a transition to an episode of opposite polarity (for example, an episode with major depression to a manic episode). An essential feature of bipolar disorder with rapid cycling is the occurrence of at least four episodes of mood over the previous 12 months. These episodes can occur in any combination and order. Episodes should meet the criteria for both the duration and the number of symptoms for a major depressive, manic, or hypomanic episode and should be limited to either a period of complete remission or a transition to an episode of opposite polarity. Manic and hypomaniac episodes are considered to be at the same pole. Except for the fact that they occur more often, the episodes that occur in the fast-cycle pattern are no different from the episodes that occur in the non- rapid -cycle mode. The episodes of mood that are taken into account when determining the fast cycle pattern exclude those episodes that are directly caused by the substance (for example, cocaine, corticosteroids) or another disease [2].
The crucial issue is demonstrated by reviewing the literature that the effect of the combined use of carbamazepine and lithium in the treatment of outpatients with Rapid cycle bipolar disorder without psychiatric comorbidity has not been studied in a double-blind placebo-controlled design. This study reports on a randomized, double-blind, placebo-controlled of carbamazepine and lithium in the treatment of outpatients with Rapid cycle bipolar disorder. The aim of this work was to study the effectiveness of carbamazepine in combination with lithium in the treatment of rapid- cycle bipolar disorder in the framework of type I bipolar disorder.
This was a double-blind, placebo-controlled trial for patients diagnosed with DSM-5for rapid cycle bipolar disorder. The patients gave their informed, written consent to participate.
In accordance with the Helsinki Declaration of the World Medical Association “Recommendations for doctors engaged in biomedical research involving people”, adopted by the 18th World Medical Assembly (Finland, 1964, revised in Japan in 1975, Italy - 1983, Hong Kong - 1989, the South African Republic - 1996, Edinburgh - 2000); The Constitution of the Republic of Azerbaijan, the Law “On Psychiatric Assistance” (adopted on 12.06.2001, with amendments and additions -11.11.2011, Decisions of the Cabinet of Ministers of the Republic of Azerbaijan No. 83, dated April 30, 2010 “On Approval of the Rules for Conducting Scientific, Preclinical and Clinical studies of medicines” are established. The conditions of the conducted researches corresponded to the generally accepted norms of morality, the requirements of ethical and legal norms, as well as the rights, interests and personal dignity of the participants of the studies were observed.
The study periods: from January 1, 2016 to January 2019. Patients were observed at the Mental Health Center of the Ministry of Health of the Republic of Azerbaijan.
Also we excluded sexually active subjects with active or unstable epilepsy, other genetic syndromes or congenital infections associated with autistic-like syndromes, prematurity; subjects who have been treated within the previous 30 days by any medication known to have a clearly defined potential for toxicity or with any psychotropic drugs; subjects with clinically significant abnormalities in laboratory tests or physical examination; subjects with a history of hypersensitivity or serious side effects associated with the use of carbamazepine and lithium, and subjects who, during the previous 3 months, started new non-pharmacological procedures, such as diet, vitamins and psychosocial therapy. A detailed clinical interview with parents by a clinical expert, accompanied by physical examination and blood analysis, was used to ensure that subjects did not meet any exclusion criteria.
This was a double-blind, placebo-controlled trial for patients diagnosed with DSM-5 for rapid cycle bipolar disorder. A structured clinical interview, for DSM-5Axis I Disorder, Patient Edition, was used to diagnose rapid cycle bipolar disorder according to DSM-5. Eighty patients (40 men and 40 women) whom we studied were under observation in Mental Clinic for Outpatients of Baku City of Azerbaijan Republic. The length of the washout was 2 weeks. Patients were washout from the all medications. The method of randomization was given by lottery. Each patient was randomized to receive either combined use of carbamazepine and lithium (40 patients) accordingly, in doses of 200 mg three times and 300 mg three times per day for 12 weeks or matched placebo (48 patients) in a double-blind manner. All patients were evaluated by experienced clinicians. The average level of concentration of carbamazepine and lithium in the blood plasma in patients was 7.8 ± 5.9 μg / ml and 0.6 - 0.8 mmol / l, respectively, range.
Eligible participants, in addition to meeting the DSM-5criteria for rapid cycling bipolar disorder and were required to be between 18 and 65 years of age. We excluded serious medical conditions including with other psychiatric disorders (e.g. bipolar disorder II tipi, schizophrenia, patients judged to be at serious suicidal or homicidal risk, dependence of psixoaktive drugs, somatic, neurological illness et c). Also we excluded unstable epilepsy, other genetic syndromes or congenital infections associated with autistic-like syndromes, prematurity; subjects who have been treated within the previous 30 days by any medication known to have a clearly defined potential for toxicity or with any psychotropic drugs; subjects with clinically significant abnormalities in laboratory tests or physical examination; subjects with a history of hypersensitivity or serious side effects associated with the use of carbamazepine and lithium, and subjects who, during the previous 3 months, started new non-pharmacological procedures, such as diet, vitamins and psychosocial therapy. A detailed clinical interview with parents by a clinical expert, accompanied by physical examination and blood analysis, was used to ensure that subjects did not meet any exclusion criteria.
Patients clinically significant of abnormal laboratory or EEG findings were ineligible. Patients before the study had used antidepressants, antipsychotics, anxiolytics, benzodiazepines, SSRI and venlafaxine. Washout of all medicines was two weeks.
Analysis of response refers to the last observation carried forward for all subjects who had valuables efficacy at baseline and with treatment. The responder analysis was conducted by using the chi-square (x2) and analysis of variance (ANOVA) according to Glantz [30].
Characteristics of the patients randomly assigned to the two treatments are shown in table 1.
Table 1. Sociodemographic characteristics of patients with rapid cycle bipolar disorder.
Characteristic | Carbamazepine + lithium n =40 | Placebo n = 40 |
| Mean SD | Mean SD |
Age (years) | 38.0 ± 10.2 | 37.4 ± 9.8 |
Duration of illness | 10.2 ± 6.0 | 10.0 ±5.8 |
| n = 40% | n = 40% |
Education: |
|
|
— primary school | 28 (70) | 30 (75) |
— secondary school | 12 (30) | 10 (25) |
Marital status: |
|
|
— never married | 10 (25) | 10 (25) |
— married | 20 (50) | 18 (45) |
— divorced | 10 (25) | 12 (30) |
or separated |
|
|
Employment status |
|
|
— unemployed | 18 (45) | 20 (50) |
— employed | 22 (55) | 20 (50) |
Note: differences between groups are not significant.
Statistical differences between the two groups are no significantly. The results of treatment are shown in Table 2. As shown from the Table 2, six patients did not return for at least one subsequent assessment, leaving 74 patients. (36 taking carbamazepine and lithium and 38 taking placebo) in the valuables study group.
The responder was conducted by X2 demonstrated superior for carbamazepine and lithium than for placebo (Table2). Carbamazepine and lithium was generally well tolerated by the patients in the study, although more carbamazepine and lithium -treated patients (n = 2) discontinued the study early because of adverse events. The two common side effects leading to discontinuation in the carbamazepine and lithium group were allergic reaction and drowsiness. Sweating a frequent complaint during placebo treatment occurred in two of 38 men. There were not unexpected or serious adverse events.
Table 2. The results of the square analysis.
Treatment Groups
| Observed number | Expected number | chi-square (x2) |
Yes improvement* | Not improvement* | Total | |
Placebo | 6 (16.43) 26 | 32 (21.57) | 38 |
Carbamazepine + lithium | 27 (15.56) | 9 (20.43) | 36
|
Total | 33 | 41 | 74 |
Note: expected numbers indication in the brackets. X2 = 22.68, df (degree of freedom) = 1, p< 0.001.
Of the 38 placebo groups, only 6 (Yes improvement *) patients had intermission over three years. Not improvement * - In 32 patients with placebo groups, no intermission was observed.
Carbamazepine + lithium group of patients: of 36 patients, 27 patients experienced intermission for three years (Yes improvement *). Not improvement * - Carbamazepine + lithium group of patients: only 9 patients did not experience intermission.
History and Discovery, structure–activity relationships, pharmacological profiles, mechanisms of action, pharmacokinetics and disposition, indications and efficacy response, side effects and toxicology, drug–drug interactions lithium and carbamazepine are described in detail in the literature [29]. Therefore, we will not dwell on them.
To our knowledge, this is the first report of a randomized, double-blind, placebo-controlled study of a Carbamazepine + lithium in the treatment of outpatients with Rapid cycle bipolar disorder without psychiatric comorbidity. Our data suggest that Carbamazepine + lithium) is efficacious in the management of rapid cycling bipolar disorder, as the participants had a clinically and statistically significant improvement in rapid cycling bipolar disorder over 12 weeks of treatment.
From the eighty patients six patients did not return for at least one subsequent assessment, leaving 74 patients (36 Carbamazepine + lithium and 38 taking placebo) in the valuables study group. Twenty six (94%) of the 36 Carbamazepine + lithium treated participants responded by 12 weeks, versus six (16%) of the 38 placebo-treated participants. The most common and problematic side effect in the carbamazepine and lithium group was on one allergic reaction and drowsiness. As a side effects in the placebo group indicated headache and sleeplessness.
As noted at the beginning pharmacotherapy for rapid cycle bipolar disorder is an active area of research. Pharmacotherapy for rapid cycle bipolar disorder is still very relevant [15, 21,24].
Our data partially coincide with some results of studies by other authors [13, 16]. It was found that carbamazepine has very limited possibilities in the treatment of rapid cycles, especially in the form of monotherapy. It has moderately pronounced effectiveness in the manic phase and weakly moderately effective in the depressive phase. [5].
At least 8 placebo-controlled randomized trials have demonstrated that lithium is a prophylactic in bipolar disorder. [21]. A meta-analysis of 16 studies of bipolar disorder conducted by Tondo and colleagues [29]. Tondo L, Hennen J, Baldessarini RJ. showed that lithium can be considered first-line treatment in the prevention of rapid cyclic bipolar disorder. Many studies confirm the effectiveness of lithium as a mood stabilizer [3, 7, 11, 19, 22, and 29].
Despite the obvious limitation of this study due to the small number of samples, we can argue that it shows promising data on the usefulness of the combined use of carbamazepine and lithium in the treatment of outpatients with Rapid cycle bipolar disorder in the routine treatment of complex pathologies in this illness. It will be important to explore further effects of the combined use of carbamazepine and lithium in the treatment of rapid cycle bipolar disorder
As indicated earlier, rapidly recurring bipolar disorders are difficult to treat. Treatment should be based on current practical guidelines and expert advisory groups on the treatment of bipolar disorder. Historically, rapid cycles usually did not respond to lithium or carbamazepine. The long-term result of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients in a lithium clinic. Data from the largest prospective, placebo-controlled, rapid-cycle bipolar disorder study demonstrated the efficacy of lamotrigine in patients with euthyma or mood episodes. Used a 6-week titration of lamotrigine to 200 mg / day. The results of these data showed that lamotrigine monotherapy was a useful treatment, especially for patients with rapid- cyclic bipolar II disorder [20, 21]. More recent comparisons of lithium and valproic acid show no significant differences in efficacy between lithium and divalproate for long-term treatment of raipd-cycle bipolar disorder, but have shown that lamotrigine has the potential to complement both drugs in the treatment of depression [6].
Our Follow-up observation (catamnesus) was conducted from January 01, 2016 to July 01, 2019. The results of follow-up observations showed that patients receiving carbamazepine in combination with lithium are in a state in full remission during for 3 years.
1) the study must be carried out on a large number of populations; 2) the study must be carried out separately for women and men; 3) study intermission duration of more than five years.
The authors declare that the article is submitted on behalf of all authors. None of the material in the article has been published previously in any form and none of the material is currently under consideration for publication elsewhere other than noted in the cover letter to the editor. Authors declare no financial and personal relationship with other people or organizations that could inappropriately influence this work. All authors contributed to and have approved the final article. The authors declare no conflicts of interest. No sponsor provided funding for this study. Mental Health Center of the Ministry of Health of the Republic of Azerbaijan provided the outpatient unit, the material for clinical and neuro-psychological assessments, and electronic resources.
The authors would like to thank staff of the Mental Health Center of the Ministry of Health of the Republic of Azerbaijan.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
